CoChat

Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness

Open access
Jopson, Laura, Khanna, Amardeep, Peterson, Patricia, Rudell, Elaine, Corrigan, Margaret, Jones, David · 2018 · Digestive Diseases and Sciences

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Background Primary Biliary Cholangitis (PBC, formerly cirrhosis), is a chronic cholestatic liver disease which until spring 2016 had a single licensed therapy, Ursodeoxycholic acid (UDCA). Approximately 30% of patients do not respond to UDCA, and are high-risk for progressing to end stage liver disease, transplantation or death. A new era of stratified medicine with second-line therapies to treat high-risk disease is emerging, with the first such second-line agent obeticholic acid recently receiving FDA and EMA approval and entering practice. Recent experience in the USA of inappropriate use and associated deaths has highlighted concerns as to whether clinicians have the knowledge to implement second-line therapies appropriately and safely. Methods Online survey of knowledge regarding optimal PBC management in Gastroenterologists and Hepatologists in the USA; the first 100 completed responses from each group used for analysis. Results 80% of Hepatologists felt they were highly competent in their understanding of the importance of early diagnosis and early UDCA therapy in PBC compared with 65% of gastroenterologists. However, only 36% of Hepatologists and 30% of gastroenterologists felt competent at assessing response to UDCA. Competence in knowledge (mode of action, efficacy, and side effects) of second-line therapies and enrollment into trials was low among both groups. Conclusion Significant knowledge gaps in clinicians managing PBC presents a problem in optimizing care. It…

Overview

Integrity signals

Registry

Crossref · 10.1007/s10620-018-5074-8

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 22 references

Cited by

See all 9

Metadata

Authors
Jopson, L., Khanna, A., Peterson, P., Rudell, E., Corrigan, M., & Jones, D.
Affiliations
  • Newcastle University (GB)
  • University of Birmingham (GB)
Corresponding author
Jones, David
Venue
Digestive Diseases and Sciences
Published
2018-05-08
Volume
63
Issue
10
Pages
2547-2554
ISSN
  • 0163-2116 (ISSN-L)
  • 1573-2568
OpenAlex
W2801516872
Cited by
9
References
22
Citations by year
2026: 3 · 2024: 1 · 2023: 1 · 2022: 1 · 2020: 1 · 2018: 2
FWCI
0.47
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Digestive Diseases and Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Medical Research Council
  • Projects in Knowledge
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
primary biliary cirrhosis, stratified medicine, obeticholic acid, ursodeoxycholic acid, second-line therapy, clinician knowledge, treatment response assessment, inappropriate medication use, hepatologists, gastroenterologists, clinical competence, disease progression
MeSH terms
Gastroenterologists, Chenodeoxycholic Acid, Cholagogues and Choleretics, Clinical Competence, Humans, Liver Cirrhosis, Biliary, Risk Factors, Ursodeoxycholic Acid, Disease Progression, Early Diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness. https://app.cochat.ai/papers/10.1007/s10620-018-5074-8
The paper
Jopson, L., Khanna, A., Peterson, P., Rudell, E., Corrigan, M., & Jones, D. (2018). Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-018-5074-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.